Recombinant Ostreid herpesvirus 1 Uncharacterized protein ORF82 (ORF82)

Shipped with Ice Packs
In Stock

Product Specs

Form
Lyophilized powder
Note: While we prioritize shipping the format currently in stock, please specify your format preference during order placement for customized preparation.
Lead Time
Delivery times vary depending on the purchasing method and location. Please contact your local distributor for precise delivery estimates.
Note: Standard shipping includes blue ice packs. Dry ice shipping requires prior arrangement and incurs additional charges.
Notes
Avoid repeated freeze-thaw cycles. Store working aliquots at 4°C for up to one week.
Reconstitution
Centrifuge the vial briefly before opening to consolidate the contents. Reconstitute the protein in sterile deionized water to a concentration of 0.1-1.0 mg/mL. For long-term storage, we recommend adding 5-50% glycerol (final concentration) and aliquoting at -20°C/-80°C. Our standard glycerol concentration is 50%, serving as a guideline for your use.
Shelf Life
Shelf life depends on storage conditions, buffer composition, temperature, and protein stability. Generally, liquid formulations have a 6-month shelf life at -20°C/-80°C, while lyophilized formulations have a 12-month shelf life at -20°C/-80°C.
Storage Condition
Upon receipt, store at -20°C/-80°C. Aliquot for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
The tag type is determined during the manufacturing process.
The tag type is determined during production. If you require a specific tag, please inform us; we will prioritize its development.
Synonyms
ORF82; Uncharacterized protein ORF82
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-296
Protein Length
full length protein
Purity
>85% (SDS-PAGE)
Species
Ostreid herpesvirus 1 (isolate France) (OsHV-1) (Pacific oyster herpesvirus)
Target Names
ORF82
Target Protein Sequence
MENGLNGTFV LKTAAGANII GHTAQFDHGI NIHWMKDLLR CKAIKPGVLA NKGVINTSAY PVTIYNTGTT DLHINDKLWV LPPLTDKAMQ TTMFEGNVFP PEVYEKTFIQ AELSQFIDDM ILLHELSTAV PLKKVNTESV AEKNFSTALG VKALGDQLSS NFFWKRLVAA YYNHNRYSTP EEVKLGIFRF ISKNWIMHLI ESPKGTSSRY NNLFKSWSAV GANFTLHPSQ EFDTMEGASK SEEYLKNIFF MRSFLTAIKH AANTWVEFKM PTVGTITGAK ETHIRPNHDF SLTLTM
Uniprot No.

Q&A

What is Ostreid herpesvirus 1 and why is ORF82 protein important?

Ostreid herpesvirus 1 (OsHV-1) is a member of the Malacoherpesviridae family that has been regularly detected in Crassostrea gigas, particularly associated with mortality outbreaks in juvenile oysters . The virus genome encodes numerous proteins, many of which remain uncharacterized, including ORF82. Studying uncharacterized proteins like ORF82 is critical for understanding viral pathogenesis, developing diagnostic tools, and potentially creating intervention strategies to prevent mortality events in oyster populations.

The OsHV-1 genome has been fully sequenced, revealing 125 putative open reading frames (ORFs) in variants such as the Italian OsHV-1 microvariant (OsHV-1-PT) . While the specific function of ORF82 remains unknown, characterizing this protein may provide insights into virus-host interactions and the mechanisms underlying oyster mortality events.

What expression systems are available for producing recombinant ORF82 protein?

Recombinant ORF82 protein can be produced using several expression systems, each with distinct advantages for different research applications. Available expression systems include:

Expression SystemAvailable QuantitiesApplicationsAdvantages
E. coli0.05 mg, 0.2 mg, 0.5 mgStructural studies, antibody production, biochemical assaysHigh yield, cost-effective, rapid production
Baculovirus0.05 mgFunctional studies, protein-protein interactionsPost-translational modifications, eukaryotic expression
Yeast0.2 mgLarge-scale production, some post-translational modificationsScalable, intermediate between bacterial and mammalian systems

Selection of the appropriate expression system should be based on the specific research questions being addressed and the downstream applications . For structural studies requiring large quantities of protein, E. coli systems may be preferable, while functional studies might benefit from baculovirus expression to maintain appropriate post-translational modifications.

How can I verify the identity and purity of recombinant ORF82 protein?

Verification of recombinant ORF82 identity and purity involves multiple complementary approaches:

  • SDS-PAGE analysis: Examining the molecular weight and comparing it to the predicted size based on the amino acid sequence.

  • Western blot: Using anti-tag antibodies (if the recombinant protein contains tags like His or GST) or developing specific antibodies against ORF82.

  • Mass spectrometry: Performing peptide mass fingerprinting or LC-MS/MS analysis to confirm the protein sequence.

  • Size-exclusion chromatography: Assessing the homogeneity and oligomeric state of the purified protein.

  • Dynamic light scattering: Evaluating protein monodispersity and stability.

For recombinant ORF82, maintaining appropriate controls, including known standards and negative controls, is essential for accurate identification and characterization.

What approaches can be used to determine the function of uncharacterized ORF82 protein?

Determining the function of uncharacterized viral proteins like ORF82 requires a multifaceted approach:

  • Bioinformatic analysis: Utilizing sequence homology searches, structure prediction, motif identification, and phylogenetic comparisons with other herpesviruses.

  • Protein-protein interaction studies: Employing yeast two-hybrid, co-immunoprecipitation, or proximity-dependent biotin identification (BioID) to identify viral or host protein partners.

  • Localization studies: Using fluorescently tagged recombinant ORF82 to determine subcellular localization during infection.

  • Gene knockout/knockdown experiments: Creating OsHV-1 variants with ORF82 deletions or mutations to assess effects on viral replication and pathogenesis.

  • Transcriptomic analysis: Examining when ORF82 is expressed during the viral life cycle using long-read sequencing technologies as demonstrated with other OsHV-1 genes .

  • Functional assays: Testing for specific enzymatic activities, nucleic acid binding, or structural roles.

Each approach yields complementary information that, when integrated, can provide insights into ORF82's biological role in OsHV-1 infection.

How might ORF82 contribute to OsHV-1 virulence and pathogenicity?

Based on research on OsHV-1 and other herpesviruses, uncharacterized proteins like ORF82 could contribute to virulence through several mechanisms:

  • Immune evasion: ORF82 might interfere with oyster immune responses, potentially counteracting host defense mechanisms like those involving adenosine deaminase acting on RNA (ADAR), similar to other transcription-based viral counter defense mechanisms identified in OsHV-1 .

  • Viral replication enhancement: The protein could be involved in viral DNA replication, capsid assembly, or viral egress, contributing to efficient production of viral particles.

  • Host cell manipulation: ORF82 might alter host cell functions to create an environment favorable for viral replication, potentially contributing to cytopathic effects.

  • Temperature-dependent effects: Given that OsHV-1 detection and mortality events are significantly associated with summer months and temperature increases , ORF82 might have temperature-dependent functions that contribute to virulence under specific environmental conditions.

Understanding ORF82's role would require correlating its expression and activity with viral load measurements and mortality rates in experimental infection models.

What is known about RNA editing events in OsHV-1 and how might this affect ORF82 expression?

Recent long-read transcriptomic studies have revealed RNA editing events in OsHV-1, likely mediated by host adenosine deaminase acting on dsRNA (ADAR1) . This RNA editing process can convert adenosine to inosine in viral transcripts, potentially altering the coding sequence and resulting protein products.

For ORF82, potential RNA editing could:

  • Create alternative protein variants through codon changes

  • Affect mRNA stability, translation efficiency, or localization

  • Serve as either a host defense mechanism or be exploited by the virus for generating diversity

The distribution of editing sites across the OsHV-1 genome appears non-random, with hyper-editing concentrated in specific regions while single-nucleotide editing is more dispersed . Determining whether ORF82 transcripts undergo editing would require targeted sequencing of ORF82 transcripts from infected oysters and comparison with the genomic sequence.

How should I design infection experiments to study ORF82 expression during OsHV-1 infection?

Designing effective infection experiments to study ORF82 requires careful consideration of several factors:

  • Oyster selection: Use OsHV-1-free Crassostrea gigas from certified sources, preferably of uniform age and genetic background. Juvenile oysters are typically more susceptible to OsHV-1 infection .

  • Viral inoculum preparation: Prepare fresh inocula from gills and mantle fragments of infected oysters with high viral titers (above 10^6 OsHV-1 copies/μl). For consistent results, aim for an injection dose of 10^7-10^8 OsHV-1 DNA copies, as this range has been associated with significant mortality rates .

  • Temperature conditions: Maintain experimental tanks at temperatures that support viral replication (typically summer temperatures or rapid temperature increases), as OsHV-1 detection is significantly associated with temperature patterns .

  • Sampling timeline: Collect samples at multiple timepoints:

    • Pre-infection (control)

    • Early infection (6-24 hours post-infection)

    • Peak infection (48-72 hours post-infection)

    • Late infection (96+ hours post-infection)

  • Analysis methods:

    • Quantify viral load using qPCR targeting conserved regions like ORF100

    • Measure ORF82 transcript levels using RT-qPCR

    • Detect ORF82 protein using specific antibodies or tagged recombinant constructs

    • Document mortality rates and clinical signs

This experimental design allows for correlation between ORF82 expression, viral replication dynamics, and host mortality.

What control experiments are necessary when studying recombinant ORF82 protein?

Rigorous control experiments are essential for meaningful interpretation of results when studying recombinant ORF82:

Control TypePurposeImplementation
Negative expression controlControl for expression system artifactsExpress an unrelated protein using the same expression system and purification methods
Tag-only controlAssess tag effectsExpress only the tag portion used in the recombinant protein
Heat-inactivated controlDistinguish between structure-dependent and independent functionsHeat-treat a portion of purified ORF82 to denature it
Concentration-matched controlsEnsure observed effects are specificUse equivalent concentrations of control proteins in all assays
Host species controlsAccount for species-specific effectsInclude experiments in both susceptible and resistant oyster species/strains
Environmental controlsAddress temperature dependenciesPerform experiments under different temperature conditions

Additionally, when expressing ORF82 in heterologous systems, comparing results across different expression platforms (E. coli, baculovirus, and yeast) can help distinguish authentic protein characteristics from expression artifacts .

How can I study ORF82 in the context of different OsHV-1 variants?

OsHV-1 exists as several variants, including the reference strain and microvariants like OsHV-1μvar and OsHV-1-PT. To study ORF82 across these variants:

  • Sequence comparison: Align the ORF82 sequences from different variants to identify conserved and variable regions. This may provide insights into functionally important domains if they are evolutionarily conserved.

  • Expression analysis: Compare ORF82 expression patterns and levels during infection with different OsHV-1 variants using strain-specific qPCR assays.

  • Recombinant protein production: Produce recombinant ORF82 proteins from multiple variants to compare their biochemical properties, interaction partners, and functional characteristics.

  • Chimeric constructs: Create chimeric ORF82 proteins combining regions from different variants to map functional domains.

  • Infection studies: Conduct comparative infection studies using different OsHV-1 variants in the same oyster population to correlate ORF82 sequence variations with pathogenicity differences.

This approach is particularly relevant since microvariants like OsHV-1μvar have been associated with higher mortality rates compared to the reference strain, with mortality reaching 80-100% in some areas .

How should RNA-Seq data be analyzed to study ORF82 expression in the context of the OsHV-1 transcriptome?

RNA-Seq analysis for studying ORF82 expression requires a comprehensive bioinformatic pipeline:

  • Quality control and preprocessing: Filter and trim low-quality reads, remove adapters, and assess sequencing quality using tools like FastQC.

  • Alignment strategies:

    • Map reads to the combined host (oyster) and viral (OsHV-1) genomes simultaneously to properly distinguish viral from host transcripts

    • Use both short-read (Illumina) and long-read (Nanopore DRS) technologies for complementary insights

  • Quantification approaches:

    • Calculate Transcripts Per Million (TPM) or Fragments Per Kilobase Million (FPKM) values for ORF82

    • Compare ORF82 expression to other viral genes to identify co-expression patterns

    • Perform time-course analysis to determine when ORF82 is expressed during infection

  • Analysis for RNA editing:

    • Identify A-to-G mismatches that may indicate adenosine-to-inosine editing

    • Distinguish between sequencing errors and true editing events using quality and coverage filters

    • Quantify editing rates at each position

  • Functional interpretation:

    • Place ORF82 within the context of temporal gene expression classes (immediate early, early, late)

    • Identify potential co-regulated gene clusters

    • Compare expression patterns between different viral strains and environmental conditions

This comprehensive approach can reveal whether ORF82 is part of conserved expression modules, such as the capsid maturation module identified in OsHV-1 .

What statistical approaches should be used when analyzing ORF82 protein interaction data?

When analyzing protein interaction data for ORF82, several statistical approaches should be employed:

  • For affinity purification-mass spectrometry (AP-MS) data:

    • Compare to appropriate negative controls using t-tests or ANOVA

    • Apply multiple testing correction (FDR or Bonferroni)

    • Use specialized scoring systems like SAINT (Significance Analysis of INTeractome) or CompPASS (Comparative Proteomics Analysis Software Suite)

    • Establish significance thresholds based on both fold-enrichment and p-values

  • For yeast two-hybrid screens:

    • Score interactions using growth on selective media and reporter gene activation strength

    • Validate with secondary screens to eliminate false positives

    • Apply confidence scoring based on multiple reporter readouts

  • Network analysis:

    • Construct protein-protein interaction networks with ORF82 at the center

    • Calculate network parameters (degree, betweenness centrality, clustering coefficient)

    • Identify statistically enriched functional categories among interaction partners

    • Compare to random networks to identify significant patterns

  • Correlation with phenotypic data:

    • Correlate interaction strength with functional outcomes in infection models

    • Use regression models to identify interactions that best predict phenotypic effects

Proper statistical analysis helps distinguish true biological interactions from background noise and contextualizes ORF82 within the viral-host protein interaction network.

How can I integrate multiple data types to determine ORF82 function in OsHV-1 pathogenesis?

Integrating diverse data types provides a comprehensive understanding of ORF82 function:

  • Multi-omics data integration:

    • Combine genomics (sequence variations), transcriptomics (expression patterns), proteomics (protein levels and modifications), and interactomics (protein interactions) data

    • Use data integration platforms like Cytoscape with appropriate plugins

    • Apply multivariate statistical methods such as principal component analysis (PCA) or partial least squares (PLS) regression

  • Temporal integration:

    • Align data from different timepoints post-infection

    • Create time-course profiles for ORF82 at multiple biological levels

    • Apply time-series analysis methods to identify causal relationships

  • Spatial integration:

    • Combine subcellular localization data with interaction networks

    • Map ORF82 activities to specific cellular compartments

    • Integrate with tissue-specific expression patterns in infected oysters

  • Mathematical modeling:

    • Develop predictive models of OsHV-1 infection incorporating ORF82 function

    • Use sensitivity analysis to determine the importance of ORF82 in model outcomes

    • Test model predictions with targeted experiments

  • Phylogenetic context:

    • Compare ORF82 with related proteins in other herpesviruses

    • Map functional data onto evolutionary relationships

    • Identify conserved mechanisms across viral families

This integrated approach can reveal how ORF82 fits into the complex molecular mechanisms of OsHV-1 pathogenesis, potentially identifying its role in the observed patchy distribution of viral infection in field settings versus more uniform patterns in nurseries .

How might understanding ORF82 function contribute to OsHV-1 control strategies?

Understanding ORF82 function could contribute to OsHV-1 control strategies through several avenues:

  • Diagnostic development: If ORF82 is consistently expressed during infection, detection of its transcripts or protein could serve as a diagnostic marker, complementing current methods that primarily target the ORF100 region .

  • Antiviral development: If ORF82 serves a critical function in the viral life cycle, it could become a target for antiviral interventions, including small molecule inhibitors or targeted antibodies.

  • Vaccine development: Recombinant ORF82 could potentially be used as an antigen in vaccination strategies if it proves immunogenic and protective.

  • Genetic selection: Identifying host factors that interact with ORF82 could inform selective breeding programs for oysters with enhanced resistance to OsHV-1 infection.

  • Environmental management: If ORF82 function is temperature-dependent, as suggested by the seasonal patterns of OsHV-1 detection , this could inform temperature management strategies in controlled aquaculture settings.

This research has particular relevance given the significant economic impact of OsHV-1 outbreaks, which can cause mortality rates of 80-100% in affected areas .

What emerging technologies might advance our understanding of ORF82 and other uncharacterized OsHV-1 proteins?

Several emerging technologies hold promise for advancing research on ORF82:

  • CRISPR-Cas systems for viral genome editing: Developing efficient methods to create targeted mutations in OsHV-1 genomes would enable direct assessment of ORF82 function during infection.

  • Single-cell RNA sequencing: Applying this technology to infected oyster tissues could reveal cell-type-specific effects of ORF82 and identify particularly susceptible host cell populations.

  • Cryo-electron microscopy: Structural determination of ORF82 alone and in complex with interaction partners could provide mechanistic insights into its function.

  • Advanced long-read sequencing: Expanding on recent applications of Nanopore DRS to study OsHV-1 transcriptomics, focusing specifically on ORF82 expression and potential RNA editing.

  • Organoid models: Developing oyster cell organoids could provide more controlled experimental systems for studying host-pathogen interactions at the cellular level.

  • Environmental DNA/RNA monitoring: Developing sensitive methods to detect and quantify ORF82 transcripts in environmental samples could improve surveillance and early warning systems.

These technologies could help address knowledge gaps regarding the molecular mechanisms underlying the temperature-dependent nature of OsHV-1 infections and the patchy distribution observed in field settings .

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.